Citations

Citations to this article as recorded by  

• CD10 Expression Correlates with Earlier Tumour Stages and Left-Sided Tumour Location in Colorectal Cancer but Has No Prognostic Impact in a European Cohort
  Julia-Kristin Grass, Katharina Grupp, Martina Kluth, Claudia Hube-Magg, Ronald Simon, Marius Kemper, Jakob R. Izbicki, Guido Sauter, Nathaniel Melling
  Cancers.2024; 16(8): 1473.     CrossRef
• Exploring cell-derived extracellular vesicles in peripheral blood and bone marrow of B-cell acute lymphoblastic leukemia pediatric patients: proof-of-concept study
  Fábio Magalhães-Gama, Marina Malheiros Araújo Silvestrini, Juliana Costa Ferreira Neves, Nilberto Dias Araújo, Fabíola Silva Alves-Hanna, Marlon Wendell Athaydes Kerr, Maria Perpétuo Socorro Sampaio Carvalho, Andréa Monteiro Tarragô, Gemilson Soares Ponte
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Pathophysiological roles and applications of glycosphingolipids in the diagnosis and treatment of cancer diseases
  Xuefeng Jin, Guang-Yu Yang
  Progress in Lipid Research.2023; 91: 101241.     CrossRef
• Expression of CD10 and CD15 in colorectal mucinous and signet ring adenocarcinomas and its relation to clinicopathological features and prognosis
  Abd AlRahman Mohammad Foda, Haitham Abdulkarem Alamer, Nadeem Ikram, Hadi Abdulhadi Helali, Fayza Sami Fayad, Sara Waleed Hussian, Khaled Abdelwahab, Tamer Akl, Ziad Emarah, Ahmed M. Ramez
  Cancer Biomarkers.2022; 33(1): 143.     CrossRef
• A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG2a-f) Exerts Antitumor Activity in a Mouse Xenograft Model of Renal Cell Cancers
  Hiroki Kawabata, Tomokazu Ohishi, Hiroyuki Suzuki, Teizo Asano, Manabu Kawada, Hiroyoshi Suzuki, Mika K. Kaneko, Yukinari Kato
  Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.2022; 41(6): 320.     CrossRef
• Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer
  Laura De Vargas Roditi, Andrea Jacobs, Jan H. Rueschoff, Pete Bankhead, Stéphane Chevrier, Hartland W. Jackson, Thomas Hermanns, Christian D. Fankhauser, Cedric Poyet, Felix Chun, Niels J. Rupp, Alexandra Tschaebunin, Bernd Bodenmiller, Peter J. Wild
  Cell Reports Medicine.2022; 3(4): 100604.     CrossRef
• Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR)
  Nicola Mitwasi, Claudia Arndt, Liliana R. Loureiro, Alexandra Kegler, Frederick Fasslrinner, Nicole Berndt, Ralf Bergmann, Vaclav Hořejší, Claudia Rössig, Michael Bachmann, Anja Feldmann
  International Journal of Molecular Sciences.2022; 23(9): 4920.     CrossRef
• Prognostic and Therapeutic Role of CD15 and CD15s in Cancer
  Wojciech Szlasa, Karol Wilk, Klaudia Knecht-Gurwin, Adam Gurwin, Anita Froń, Natalia Sauer, Wojciech Krajewski, Jolanta Saczko, Tomasz Szydełko, Julita Kulbacka, Bartosz Małkiewicz
  Cancers.2022; 14(9): 2203.     CrossRef
• Expression Profile of CD10, BCL-2, p63, and EMA in the Normal Skin and Basal Cell Carcinomas: An Immunohistochemical Reappraisal
  M.R. Hussein, A.M. Ahmed
  Actas Dermo-Sifiliográficas.2022; 113(9): 848.     CrossRef
• Targeting Aberrantly Elevated Sialyl Lewis A as a Potential Therapy for Impaired Endometrial Selection Ability in Unexplained Recurrent Miscarriage
  Zhi Ma, Huixia Yang, Mirjana Kessler, Markus Sperandio, Sven Mahner, Udo Jeschke, Viktoria von Schönfeldt
  Frontiers in Immunology.2022;[Epub]     CrossRef
• [Artículo traducido] Perfil de expresión de CD10, BCL-2, p63 y EMA en los carcinomas normales de piel y de células basales: Revaloración inmunohistoquímica
  M.R. Hussein, A.M. Ahmed
  Actas Dermo-Sifiliográficas.2022; 113(9): T848.     CrossRef
• Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy
  Simon Heumos, Sandra Dehn, Konstantin Bräutigam, Marius C. Codrea, Christian M. Schürch, Ulrich M. Lauer, Sven Nahnsen, Michael Schindler
  Cancer Cell International.2022;[Epub]     CrossRef
• High level of CD10 expression is associated with poor overall survival in patients with head and neck cancer
  Q. Li, Y. Wang, L. Xu, L. Wang, Y. Guo, C. Guo
  International Journal of Oral and Maxillofacial Surgery.2021; 50(7): 857.     CrossRef
• Expression of the Carbohydrate Lewis Antigen, Sialyl Lewis A, Sialyl Lewis X, Lewis X, and Lewis Y in the Placental Villi of Patients With Unexplained Miscarriages
  Zhi Ma, Huixia Yang, Lin Peng, Christina Kuhn, Anca Chelariu-Raicu, Sven Mahner, Udo Jeschke, Viktoria von Schönfeldt
  Frontiers in Immunology.2021;[Epub]     CrossRef
• CD15+ tumor infiltrating granulocytic cells can predict recurrence and their depletion is accompanied by good responses to S‐1 with oral cancer
  Mai Seki‐Soda, Takaaki Sano, Masaru Ogawa, Satoshi Yokoo, Tetsunari Oyama
  Head & Neck.2021; 43(8): 2457.     CrossRef
• Relationship between Immunophenotype and Clinicopathological Findings for Superficial Nonampullary Duodenal Epithelial Tumor
  Shigeki Fukusada, Takaya Shimura, Hiroyasu Iwasaki, Yusuke Okuda, Takahito Katano, Ruriko Nishigaki, Takanori Ozeki, Mika Kitagawa, Hirotada Nishie, Mamoru Tanaka, Keiji Ozeki, Eiji Kubota, Satoshi Tanida, Hiromi Kataoka
  Digestion.2021; 102(6): 870.     CrossRef
• Relationship between inflammation and the severity of Recurrent Respiratory Papillomatosis
  Vivian Narana Ribeiro El Achkar, Andressa Duarte, Román Carlos, Jorge Esquiche León, Alfredo Ribeiro-Silva, Shirley Shizue Nagata Pignatari, Estela Kaminagakura
  American Journal of Otolaryngology.2020; 41(2): 102321.     CrossRef
• Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes
  Kevin K. Leung, Gary M. Wilson, Lisa L. Kirkemo, Nicholas M. Riley, Joshua J. Coon, James A. Wells
  Proceedings of the National Academy of Sciences.2020; 117(14): 7764.     CrossRef
• Prognostic Implications of CD10 and CD15 Expression in Papillary Thyroid Carcinoma
  Eun Ji Oh, Andrey Bychkov, Haejin Cho, Tae-Min Kim, Ja Seong Bae, Dong-Jun Lim, Chan Kwon Jung
  Cancers.2020; 12(6): 1413.     CrossRef
• Is There Such a Thing as a Genuine Cancer Stem Cell Marker? Perspectives from the Gut, the Brain and the Dental Pulp
  Crende Olatz, García-Gallastegui Patricia, Luzuriaga Jon, Badiola Iker, de la Hoz Carmen, Unda Fernando, Ibarretxe Gaskon, Pineda Jose Ramon
  Biology.2020; 9(12): 426.     CrossRef
• Neprilysin expression and functions in development, ageing and disease
  NN Nalivaeva, IA Zhuravin, AJ Turner
  Mechanisms of Ageing and Development.2020; 192: 111363.     CrossRef
• A Risk Signature With Inflammatory and T Immune Cells Infiltration in Colorectal Cancer Predicting Distant Metastases and Efficiency of Chemotherapy
  Xiang Hu, Ya-Qi Li, Xiao-ji Ma, Long Zhang, San-Jun Cai, Jun-Jie Peng
  Frontiers in Oncology.2019;[Epub]     CrossRef
• Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer
  Heng Zhang, Hao Liu, Zhenbin Shen, Chao Lin, Xuefei Wang, Jing Qin, Xinyu Qin, Jiejie Xu, Yihong Sun
  Annals of Surgery.2018; 267(2): 311.     CrossRef
• Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy
  Athanasios Blanas, Neha M. Sahasrabudhe, Ernesto Rodríguez, Yvette van Kooyk, Sandra J. van Vliet
  Frontiers in Oncology.2018;[Epub]     CrossRef
• Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data
  Henning Reis, Ulrich Krafft, Christian Niedworok, Orsolya Módos, Thomas Herold, Mark Behrendt, Hikmat Al-Ahmadie, Boris Hadaschik, Peter Nyirady, Tibor Szarvas
  Disease Markers.2018; 2018: 1.     CrossRef
• CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer
  Teresa P. Raposo, Mireia Sueca Comes, Adeyemi Idowu, Bora Agit, James Hassall, Wakkas Fadhil, Robert Nica, Rupert Ecker, Takashi Yao, Mohammad Ilyas
  Experimental and Molecular Pathology.2018; 104(3): 190.     CrossRef
• High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer
  Ryan S. Berry, Meng-Jun Xiong, Alissa Greenbaum, Parisa Mortaji, Robert A. Nofchissey, Fred Schultz, Cathleen Martinez, Li Luo, Katherine T. Morris, Joshua A. Hanson, Masaru Katoh
  PLOS ONE.2017; 12(12): e0188799.     CrossRef
• Tissue expression of CD10 and CD15 proteins in gastric lesions
  Omneya Y. Bassyoni, Sarah N. Nasif
  Egyptian Journal of Pathology.2017; 37(2): 321.     CrossRef
• Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-Endopeptidase
  Zijie Feng, Lei Wang, Yanmei Sun, Zongzhe Jiang, John Domsic, Chiying An, Bowen Xing, Jingjing Tian, Xiuheng Liu, David C. Metz, Xiaolu Yang, Ronen Marmorstein, Xiaosong Ma, Xianxin Hua
  Cancer Research.2017; 77(2): 401.     CrossRef
• Does CD10 Expression Predict Lymph Node Metastasis in Colorectal Cancer?
  Irina Bernescu, Ari C. Reichstein, Martin Luchtefeld, James W. Ogilvie
  Diseases of the Colon & Rectum.2016; 59(1): 22.     CrossRef
• Epigenetic suppression of neprilysin regulates breast cancer invasion
  H M Stephen, R J Khoury, P R Majmudar, T Blaylock, K Hawkins, M S Salama, M D Scott, B Cosminsky, N K Utreja, J Britt, R E Conway
  Oncogenesis.2016; 5(3): e207.     CrossRef
• Substance P and thiorphan synergically enhance angiogenesis in wound healing
  Jihyun Um, Jinyeong Yu, Maria Jose Dubon, Ki-Sook Park
  Tissue Engineering and Regenerative Medicine.2016; 13(2): 149.     CrossRef
• Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development
  Magdalena Mizerska-Kowalska, Agnieszka Bojarska-Junak, Joanna Jakubowicz-Gil, Martyna Kandefer-Szerszeń
  Tumor Biology.2016; 37(10): 13355.     CrossRef
• Stage-Specific Embryonic Antigen-1 (SSEA-1) Expression in Thyroid Tissues
  Jin Xu, Heather Hardin, Ranran Zhang, Kaitlin Sundling, Darya Buehler, Ricardo V. Lloyd
  Endocrine Pathology.2016; 27(4): 271.     CrossRef
• Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis
  Deepshikha Mishra, Sunita Singh, Gopeshwar Narayan
  Molecular Biology International.2016; 2016: 1.     CrossRef
• Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue
  Paul R. Gielen, Barbara M. Schulte, Esther D. Kers-Rebel, Kiek Verrijp, Harriëtte M.J.M. Petersen-Baltussen, Mark ter Laan, Pieter Wesseling, Gosse J. Adema
  Journal of Neuropathology & Experimental Neurology.2015; 74(5): 390.     CrossRef
• Immunohistochemical Characterization of Large Intestinal Adenocarcinoma in the Rhesus Macaque (Macaca mulatta)
  C. E. Harbison, F. Taheri, H. Knight, A. D. Miller
  Veterinary Pathology.2015; 52(4): 732.     CrossRef
• Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
  Meixiao Shen, Pingping Hu, Frede Donskov, Guanghui Wang, Qi Liu, Jiajun Du, William B. Coleman
  PLoS ONE.2014; 9(6): e98259.     CrossRef

Citations

Citations to this article as recorded by  

• Vascular, adipose tissue, and/or calyceal invasion in clear cell tubulopapillary renal cell tumour: potentially problematic diagnostic scenarios
  Ankur R Sangoi, Harrison Tsai, Lara Harik, Jonathan Mahlow, Maria Tretiakova, Sean R Williamson, Michelle S Hirsch
  Histopathology.2024; 84(7): 1167.     CrossRef
• Clinical features and Surgical Outcome of Clear Cell Papillary Renal Cell Tumor: result from a prospective cohort
  Si Hyun Kim, Jang Hee Han, Seung-hwan Jeong, Hyeong Dong Yuk, Ja Hyeon Ku, Cheol Kwak, Hyeon Hoe Kim, Kyung Chul Moon, Chang Wook Jeong
  BMC Urology.2023;[Epub]     CrossRef
• Coexistence of multiple clear cell papillary renal cell carcinoma with renal oncocytoma: a case report
  Amine Hermi, Ahmed Saadi, Seif Mokadem, Ahlem Blel, Marouene Chakroun, Mohamed Riadh Ben Slama
  Annals of Medicine & Surgery.2023; 85(5): 2017.     CrossRef
• Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update
  Ziad M. El-Zaatari, Luan D. Truong
  Biomedicines.2022; 10(3): 657.     CrossRef
• The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management
  Stanley Weng, Renzo G. DiNatale, Andrew Silagy, Roy Mano, Kyrollis Attalla, Mahyar Kashani, Kate Weiss, Nicole E. Benfante, Andrew G. Winer, Jonathan A. Coleman, Victor E. Reuter, Paul Russo, Ed Reznik, Satish K. Tickoo, A. Ari Hakimi
  European Urology.2021; 79(4): 468.     CrossRef
• Clear cell papillary renal cell carcinoma: Characteristics and survival outcomes from a large single institutional series
  James E. Steward, Sean Q. Kern, Liang Cheng, Ronald S. Boris, Yan Tong, Clint D. Bahler, Timothy A. Masterson, K. Clint Cary, Hristos Kaimakliotis, Thomas Gardner, Chandru P. Sundaram
  Urologic Oncology: Seminars and Original Investigations.2021; 39(6): 370.e21.     CrossRef
• Clear cell papillary renal cell carcinoma: an update after 15 years
  Sean R. Williamson
  Pathology.2021; 53(1): 109.     CrossRef
• Clear Cell Papillary Renal Cell Carcinoma
  Jianping Zhao, Eduardo Eyzaguirre
  Archives of Pathology & Laboratory Medicine.2019; 143(9): 1154.     CrossRef
• Clear cell papillary renal cell carcinoma – An indolent subtype of renal tumor
  Wei-Jen Chen, Chin-Chen Pan, Shu-Huei Shen, Hsiao-Jen Chung, Chih-Chieh Lin, Alex T.L. Lin, Yen-Hwa Chang
  Journal of the Chinese Medical Association.2018; 81(10): 878.     CrossRef
• Clear cell papillary renal cell carcinoma: A case report and review of the literature
  Sung Han Kim, Whi-An Kwon, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee, Jinsoo Chung
  World Journal of Nephrology.2018; 7(8): 155.     CrossRef
• Clinical features and survival analysis of clear cell papillary renal cell carcinoma: A 10‑year retrospective study from two institutions
  Yiqiu Wang, Ying Ding, Jian Wang, Min Gu, Zengjun Wang, Chao Qin, Conghui Han, Hongxia Li, Xia Liu, Pengfei Wu, Guangchao Li
  Oncology Letters.2018;[Epub]     CrossRef
• A contemporary series of renal masses with emphasis on recently recognized entities and tumors of low malignant potential: A report based on 624 consecutive tumors from a single tertiary center
  Maria Rosaria Raspollini, Ilaria Montagnani, Rodolfo Montironi, Liang Cheng, Guido Martignoni, Andrea Minervini, Sergio Serni, Giulio Nicita, Marco Carini, Antonio Lopez-Beltran
  Pathology - Research and Practice.2017; 213(7): 804.     CrossRef
• Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma
  Hari P. Dhakal, Jesse K. McKenney, Li Yan Khor, Jordan P. Reynolds, Cristina Magi-Galluzzi, Christopher G. Przybycin
  American Journal of Surgical Pathology.2016; 40(2): 141.     CrossRef
• New and emerging renal tumour entities
  Naoto Kuroda, Ondřej Hess, Ming Zhou
  Diagnostic Histopathology.2016; 22(2): 47.     CrossRef
• Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features
  Hanan AlSaeid Alshenawy
  Pathology & Oncology Research.2015; 21(4): 893.     CrossRef
• Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features
  Hanan AlSaeid Alshenawy
  Journal of Microscopy and Ultrastructure.2015; 3(2): 68.     CrossRef
• Clear Cell-Papillary Renal Cell Carcinoma of the Kidney Not Associated With End-stage Renal Disease
  Manju Aron, Elena Chang, Loren Herrera, Ondrej Hes, Michelle S. Hirsch, Eva Comperat, Philippe Camparo, Priya Rao, Maria Picken, Michal Michal, Rodolfo Montironi, Pheroze Tamboli, Federico Monzon, Mahul B. Amin
  American Journal of Surgical Pathology.2015; 39(7): 873.     CrossRef
• Papillary or pseudopapillary tumors of the kidney
  Fang-Ming Deng, Max X. Kong, Ming Zhou
  Seminars in Diagnostic Pathology.2015; 32(2): 124.     CrossRef
• Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
  Mairo L. Diolombi, Liang Cheng, Pedram Argani, Jonathan I. Epstein
  American Journal of Surgical Pathology.2015; 39(12): 1621.     CrossRef
• Targeted next‐generation sequencing and non‐coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes
  Charles H Lawrie, Erika Larrea, Gorka Larrinaga, Ibai Goicoechea, María Arestin, Marta Fernandez‐Mercado, Ondrej Hes, Francisco Cáceres, Lorea Manterola, José I López
  The Journal of Pathology.2014; 232(1): 32.     CrossRef
• Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma
  Haijun Zhou, Shaojiang Zheng, Luan D. Truong, Jae Y. Ro, Alberto G. Ayala, Steven S. Shen
  Human Pathology.2014; 45(1): 59.     CrossRef
• Clear cell papillary renal cell carcinoma: Incidence, morphological features, immunohistochemical profile, and biologic behavior: A single institution study
  Borislav A. Alexiev, Cinthia B. Drachenberg
  Pathology - Research and Practice.2014; 210(4): 234.     CrossRef
• MRI Phenotype in Renal Cancer
  Naomi Campbell, Andrew B. Rosenkrantz, Ivan Pedrosa
  Topics in Magnetic Resonance Imaging.2014; 23(2): 95.     CrossRef